X-57331677-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_174912.4(FAAH2):c.492G>A(p.Lys164=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,209,915 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000026 ( 0 hom. 7 hem. )
Consequence
FAAH2
NM_174912.4 synonymous
NM_174912.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.67
Genes affected
FAAH2 (HGNC:26440): (fatty acid amide hydrolase 2) This gene encodes a fatty acid amide hydrolase that shares a conserved protein motif with the amidase signature family of enzymes. The encoded enzyme is able to catalyze the hydrolysis of a broad range of bioactive lipids, including those from the three main classes of fatty acid amides; N-acylethanolamines, fatty acid primary amides and N-acyl amino acids. This enzyme has a preference for monounsaturated acyl chains as a substrate. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant X-57331677-G-A is Benign according to our data. Variant chrX-57331677-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3039659.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=2.67 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAAH2 | NM_174912.4 | c.492G>A | p.Lys164= | synonymous_variant | 4/11 | ENST00000374900.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAAH2 | ENST00000374900.5 | c.492G>A | p.Lys164= | synonymous_variant | 4/11 | 1 | NM_174912.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111991Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34147
GnomAD3 genomes
AF:
AC:
1
AN:
111991
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34147
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000120 AC: 22AN: 183154Hom.: 0 AF XY: 0.0000886 AC XY: 6AN XY: 67716
GnomAD3 exomes
AF:
AC:
22
AN:
183154
Hom.:
AF XY:
AC XY:
6
AN XY:
67716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000264 AC: 29AN: 1097924Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 7AN XY: 363326
GnomAD4 exome
AF:
AC:
29
AN:
1097924
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
363326
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111991Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34147
GnomAD4 genome
AF:
AC:
1
AN:
111991
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34147
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FAAH2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 27, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at